Centers

Collaborative Drug Discovery, Inc.

EU-OPENSCREEN

UCSC Chemical Screening Center

Chemical registration system

Activity & Registration - Web application within CDD Vault for chemical registration, assay data management, and SAR analysis.

Scientific visualization
Visualization - Web application within CDD Vault allowing...


Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of...

Read more

Partnerships

Events

Jobs

GSK and MD Anderson to co-develop new cancer therapeutics

GlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusive rights to antibodies developed during the...

 
View all

Evotec and Yale University form Open Innovation Alliance

Evotec and Yale intend to leverage first rate science performed at Yale University together with Evotec's drug discovery infrastructure and expertise into highly innovative discovery approaches in diseases of high unmet medical need. Initially,...

 
View all

Novartis and University of Pennsylvania form Alliance in Oncology Area

University of Pennsylvania and Novartis have joined hands together to start a new Center for Advanced Cellular Therapies (CACT). The new center will be based out of University of Pennsylvania campus and will be responsible to develop T Cell...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All